PARDES BIOSCIENCES INC's ticker is and the CUSIP is 69945Q105. A total of 1 filers reported holding PARDES BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $11,134,696 | +37.1% | 6,151,766 | 0.0% | 1.26% | +5.2% |
Q1 2023 | $8,120,331 | -21.9% | 6,151,766 | 0.0% | 1.20% | -34.3% |
Q4 2022 | $10,396,485 | -8.7% | 6,151,766 | 0.0% | 1.83% | +8.0% |
Q3 2022 | $11,381,000 | -39.7% | 6,151,766 | 0.0% | 1.70% | -39.8% |
Q2 2022 | $18,886,000 | – | 6,151,766 | – | 2.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Opportunity Management V, LLC | 5,227,307 | $37,741,000 | 52.85% |
Foresite Capital Management V, LLC | 9,400,515 | $67,872,000 | 27.72% |
Lynx1 Capital Management LP | 1,642,834 | $11,861,000 | 11.01% |
Frazier Life Sciences Management, L.P. | 2,081,007 | $15,025,000 | 1.28% |
RA Capital Management | 6,175,038 | $44,584,000 | 0.97% |
Arena Capital Advisors, LLC- CA | 851,281 | $6,146,000 | 0.93% |
DAFNA Capital Management LLC | 421,157 | $3,041,000 | 0.79% |
Sio Capital Management, LLC | 315,564 | $2,278,000 | 0.75% |
TCG Crossover Management, LLC | 229,100 | $1,654,000 | 0.66% |
Altium Capital Management LP | 253,000 | $1,827,000 | 0.61% |